Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl. 2022;12(1):7–11. https://doi.org/10.1016/j.kisu.2021.11.003.

Article  Google Scholar 

Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339–52. https://doi.org/10.1016/S0140-6736(13)60595-4.

Article  PubMed  Google Scholar 

Jain N, Hedayati SS, Sarode R, Banerjee S, Reilly RF. Antiplatelet therapy in the management of cardiovascular disease in patients with CKD: what is the evidence? Clin J Am Soc Nephrol. 2013;8(4):665–74. https://doi.org/10.2215/CJN.06790712.

Article  PubMed  CAS  Google Scholar 

Moody WE, Edwards NC, Chue CD, Ferro CJ, Townend JN. Arterial disease in chronic kidney disease. Heart. 2013;99(6):365–72. https://doi.org/10.1136/heartjnl-2012-302818.

Article  PubMed  CAS  Google Scholar 

Zamberg I, Assouline-Reinmann M, Carrera E, et al. Epidemiology, thrombolytic management, and outcomes of acute stroke among patients with chronic kidney disease: a systematic review and meta-analysis. Nephrol Dial Transplant. 2022;37(7):1289–301. https://doi.org/10.1093/ndt/gfab197.

Article  PubMed  Google Scholar 

Molnar AO, Bota SE, Garg AX, et al. The risk of major hemorrhage with CKD. J Am Soc Nephrol. 2016;27(9):2825–32. https://doi.org/10.1681/ASN.2015050535.

Article  PubMed  PubMed Central  Google Scholar 

Palmer SC, Di Micco L, Razavian M, et al. Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med. 2012;156(6):445–59. https://doi.org/10.7326/0003-4819-156-6-201203200-00007.

Article  PubMed  Google Scholar 

Baber U, Chandrasekhar J, Sartori S, et al. Associations between chronic kidney disease and outcomes with use of prasugrel versus clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a report from the PROMETHEUS study. JACC Cardiovasc Interv. 2017;10(20):2017–25. https://doi.org/10.1016/j.jcin.2017.02.047.

Article  PubMed  Google Scholar 

Tapoi L, Ureche C, Sascau R, Badarau S, Covic A. Atrial fibrillation and chronic kidney disease conundrum: an update. J Nephrol. 2019;32(6):909–17. https://doi.org/10.1007/s40620-019-00630-1.

Article  PubMed  Google Scholar 

Wanner C, Herzog CA, Turakhia MP. Chronic kidney disease and arrhythmias: highlights from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 2018;94(2):231–4. https://doi.org/10.1016/j.kint.2018.05.005.

Article  PubMed  Google Scholar 

Chugh SS, Roth GA, Gillum RF, Mensah GA. Global burden of atrial fibrillation in developed and developing nations. Glob Heart. 2014;9(1):113–9. https://doi.org/10.1016/j.gheart.2014.01.004.

Article  PubMed  Google Scholar 

Zulkifly H, Lip GYH, Lane DA. Epidemiology of atrial fibrillation. Int J Clin Pract. 2018;72(3): e13070. https://doi.org/10.1111/ijcp.13070.

Article  PubMed  Google Scholar 

Ng KP, Edwards NC, Lip GY, Townend JN, Ferro CJ. Atrial fibrillation in CKD: balancing the risks and benefits of anticoagulation. Am J Kidney Dis. 2013;62(3):615–32. https://doi.org/10.1053/j.ajkd.2013.02.381.

Article  PubMed  Google Scholar 

Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 Clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021;100(4S):S1-S276. https://doi.org/10.1016/j.kint.2021.05.021

Elenjickal EJ, Travlos CK, Marques P, Mavrakanas TA. Anticoagulation in patients with chronic kidney disease. Am J Nephrol. 2023. https://doi.org/10.1159/000535546.

Article  PubMed  Google Scholar 

Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739–91. https://doi.org/10.1093/eurheartj/ehx391.

Article  PubMed  Google Scholar 

Hemmelgarn BR, Manns BJ, Lloyd A, et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA. 2010;303(5):423–9. https://doi.org/10.1001/jama.2010.39.

Article  PubMed  CAS  Google Scholar 

Ocak G, Vossen CY, Lijfering WM, et al. Role of hemostatic factors on the risk of venous thrombosis in people with impaired kidney function. Circulation. 2014;129(6):683–91. https://doi.org/10.1161/CIRCULATIONAHA.113.002385.

Article  PubMed  Google Scholar 

Mahmoodi BK, Gansevoort RT, Næss IA, et al. Association of mild to moderate chronic kidney disease with venous thromboembolism: pooled analysis of five prospective general population cohorts. Circulation. 2012;126(16):1964–71. https://doi.org/10.1161/CIRCULATIONAHA.112.113944.

Article  PubMed  PubMed Central  Google Scholar 

Olesen JB, Lip GY, Kamper AL, et al. Stroke and bleeding in atrial fibrillation with chronic kidney disease[published correction appears in N Engl J Med. 2012 Dec 6;367(23):2262]. N Engl J Med. 2012;367(7):625–35. https://doi.org/10.1056/NEJMoa1105594.

Article  PubMed  CAS  Google Scholar 

Casserly LF, Dember LM. Thrombosis in end-stage renal disease. Semin Dial. 2003;16(3):245–56. https://doi.org/10.1046/j.1525-139x.2003.16048.x.

Article  PubMed  Google Scholar 

Lutz J, Menke J, Sollinger D, Schinzel H, Thürmel K. Haemostasis in chronic kidney disease. Nephrol Dial Transplant. 2014;29(1):29–40. https://doi.org/10.1093/ndt/gft209.

Article  PubMed  CAS  Google Scholar 

Vanholder R, Pletinck A, Schepers E, Glorieux G. Biochemical and clinical impact of organic uremic retention solutes: a comprehensive update. Toxins (Basel). 2018;10(1):33. https://doi.org/10.3390/toxins10010033.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Baaten CCFMJ, Sternkopf M, Henning T, Marx N, Jankowski J, Noels H. Platelet function in CKD: a systematic review and meta-analysis. J Am Soc Nephrol. 2021;32(7):1583-1598. https://doi.org/10.1681/ASN.2020101440

Camaioni C, Gustapane M, Cialdella P, Della Bona R, Biasucci LM. Microparticles and microRNAs: new players in the complex field of coagulation. Intern Emerg Med. 2013;8(4):291–6. https://doi.org/10.1007/s11739-011-0705-5.

Article  PubMed  Google Scholar 

Plé H, Maltais M, Corduan A, Rousseau G, Madore F, Provost P. Alteration of the platelet transcriptome in chronic kidney disease. Thromb Haemost. 2012;108(4):605–15. https://doi.org/10.1160/TH12-03-0153.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Boccardo P, Remuzzi G, Galbusera M. Platelet dysfunction in renal failure. Semin Thromb Hemost. 2004;30(5):579–89. https://doi.org/10.1055/s-2004-835678.

Article  PubMed  CAS  Google Scholar 

Dager WE, Kiser TH. Systemic anticoagulation considerations in chronic kidney disease. Adv Chronic Kidney Dis. 2010;17(5):420–7. https://doi.org/10.1053/j.ackd.2010.06.002.

Article  PubMed  Google Scholar 

Sciascia S, Radin M, Schreiber K, Fenoglio R, Baldovino S, Roccatello D. Chronic kidney disease and anticoagulation: from vitamin K antagonists and heparins to direct oral anticoagulant agents. Intern Emerg Med. 2017;12(8):1101–8. https://doi.org/10.1007/s11739-017-1753-2.

Article  PubMed  Google Scholar 

Heestermans M, Poenou G, Hamzeh-Cognasse H, Cognasse F, Bertoletti L. Anticoagulants: a short history, their mechanism of action, pharmacology, and indications. Cells. 2022;11(20):3214. https://doi.org/10.3390/cells11203214.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Derebail VK, Rheault MN, Kerlin BA. Role of direct oral anticoagulants in patients with kidney disease. Kidney Int. 2020;97(4):664–75. https://doi.org/10.1016/j.kint.2019.11.027.

Article  PubMed  CAS